InvestorsHub Logo
Followers 65
Posts 23927
Boards Moderated 0
Alias Born 11/23/2016

Re: Steady_T post# 444946

Monday, 01/01/2024 3:25:59 PM

Monday, January 01, 2024 3:25:59 PM

Post# of 462733
Going by this EU Regulatory procedures for a marketing authorisation (MA), Anavex would be in the first row "Pre-submission - Actions" of the table.

Given the PR says:

announced today that the Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency (EMA) agreed that oral blarcamesine for Alzheimer’s disease is eligible for submission of an application for a Union Marketing Authorisation in the EU under the European Medicines Agency’s centralised procedure


I would say Anavex is well through that first row now working on the MAA submission for the technical validation.

The longer we wait, the sooner we will get rich!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News